Archit Organosys Reports Mixed Financial Results Amid Profit Recovery and Sales Decline in February 2025
Archit Organosys has announced its financial results for the quarter ending December 2024, revealing a significant increase in Profit After Tax (PAT) to Rs 2.03 crore, compared to Rs 0.06 crore last year. However, net sales declined to Rs 25.87 crore, indicating challenges in sales performance.
Archit Organosys, a microcap player in the chemicals industry, has recently reported its financial results for the quarter ending December 2024. The results, declared on February 14, 2025, indicate a notable adjustment in evaluation, with the score rising to 6 from -2 over the past three months.The financial data reveals that the Profit After Tax (PAT) for the half-year period has shown a significant increase, reaching Rs 2.03 crore, compared to Rs 0.06 crore in the preceding twelve months. This performance highlights a strong recovery in profitability, as the company has already surpassed its PAT from the previous year within just half a year.
Conversely, the net sales for the quarter have presented challenges, recorded at Rs 25.87 crore, which reflects a decline of 7.9% compared to the average net sales of the previous four quarters, which stood at Rs 28.09 crore. This trend suggests a negative near-term sales trajectory for the company.
Overall, Archit Organosys's recent financial results showcase a mixed landscape, with positive developments in profitability contrasted by a downturn in sales performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
